Paris-based Orakl Oncology SA has raised €3m to develop its techbio platform for precision oncology.
Latest News
French pharma major Sanofi SA will pay US$175m upfront to Janssen Pharmaceuticals, Inc. for commercialisation of a Phase...
The Spanish EU Council Presidency is to set the course for the internationally competitive use of biotechnology in drug...
SIGN UP FOR OUR FREE NEWSLETTER
BACKGROUND
Precision medicine tailors therapeutics to individual patients’ diseases, and is seen as the future of clinical...
SERVICE
THE MAG
Current Issue
CURRENT ISSUE
Cell & Gene Therapy – Getting Europe rolling
Cell and Gene Therapies (CGTs) have emerged as one of the fastest growing sectors in the life sciences industry, even though supply chains in the...
New Special
CURRENT ISSUE
CROs & CDMOs
Since 2006, the share of biomanufacturers producing everything in-house have declined from 57.6% to 34.9% in 2022. According to biopharmaceutical...
SPECIALS
SEE ALL
PEOPLE
APPOINTMENTS
OPINION
Events
UPCOMING EVENTS
1st BIOTECH SUMMIT AUSTRIA
12.10.
- 13.10.2023
ǀ Graz (AT)
World Health Summit 2023
15.10.
- 17.10.2023
ǀ Berlin/digital
European Conference of the Global Biotech, Pharma & Healthtech Supply Chain Community – BSMA
19.10.
- 20.10.2023
ǀ Brussels (B)
European Forum for Industrial Biotechnology & the Bioeconomy – EFIB
24.10.
- 25.10.2023
ǀ Rotterdam (NL)